DUBLIN, IRELAND -- (MARKET WIRE) -- August 30, 2006 -- Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB.I), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that Brendan Farrell, President, will be speaking at the Roth Capital Partners New York Conference at 08.00 Eastern Time, on Wednesday the 6th of September. The event will be webcast and can be accessed on http://www.wsw.com/webcast/roth8/orng/.
